CD274 and neoplasm: PD-L1 on tumor cells or TILs was higher among early-stage SCLC compared with metastatic patients,64 and multiple authors demonstrated an association with better outcome in SCLC.64–68 However, limited studies reported contrary results.69 70 Different antibodies, cut-off values, and study design may cause the discrepancy.